FOLH1 and adrenal cortex carcinoma: Since the included studies reporting PSMA-targeted PET/CT detection rate in ACC used different modalities for their assessment and other benchmarks to calculate it, a meta-analysis could not be accomplished [14,15,16,17,18,19].